SMTL ID : 8qji.1

Crystal structure of GSK3b in complex with N-(4-(5-(1,2,4-oxadiazol-3-yl)thiophen-2-yl)pyridin-2-yl)cyclopropanecarboxamide inhibitor (TW362)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.02 Å

Oligo State

monomer

Ligands

1 x VNG: N-[4-[5-(1,2,4-oxadiazol-3-yl)thiophen-2-yl]pyridin-2-yl]cyclopropanecarboxamide

VNG.1: 14 residues within 4Å: Chain A: I.37, F.42, A.58, K.60, D.108, Y.109, V.110, P.111, E.112, T.113, R.116, L.163, C.174, D.175 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:I.37, A:A.58, A:K.60, A:Y.109, A:T.113, A:L.163 Hydrogen bonds: A:V.110, A:V.110

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Goral, I. et al., Exploring Novel GSK-3 beta Inhibitors for Anti-Neuroinflammatory and Neuroprotective Effects: Synthesis, Crystallography, Computational Analysis, and Biological Evaluation. Acs Chem Neurosci (2024)

Release Date

2024-09-04

Peptides

Glycogen synthase kinase-3 beta: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Glycogen synthase kinase-3 beta

Related Entries With Identical Sequence